342 related articles for article (PubMed ID: 27927793)
1. Tumour biomarkers: homeostasis as a novel prognostic indicator.
Falco M; Palma G; Rea D; De Biase D; Scala S; D'Aiuto M; Facchini G; Perdonà S; Barbieri A; Arra C
Open Biol; 2016 Dec; 6(12):. PubMed ID: 27927793
[TBL] [Abstract][Full Text] [Related]
2. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
4. Cancer epigenetics: Moving forward.
Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
[TBL] [Abstract][Full Text] [Related]
5. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of Bad Biology: Curse or a Blessing?
Banerjee S; Sicklick JK
Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488
[No Abstract] [Full Text] [Related]
7. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers.
Chan TA; Baylin SB
Curr Top Microbiol Immunol; 2012; 355():189-216. PubMed ID: 21818705
[TBL] [Abstract][Full Text] [Related]
9. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
10. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
[TBL] [Abstract][Full Text] [Related]
11. Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy.
Claes B; Buysschaert I; Lambrechts D
Heredity (Edinb); 2010 Jul; 105(1):152-60. PubMed ID: 20389307
[TBL] [Abstract][Full Text] [Related]
12. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
Wooten DJ; Quaranta V
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
14. [Precision medicine from experimental to clinical applications in oncology].
Normanno N
Recenti Prog Med; 2015 Dec; 106(12):597-600. PubMed ID: 26780068
[TBL] [Abstract][Full Text] [Related]
15. Translating cancer epigenomics into the clinic: focus on lung cancer.
Mari-Alexandre J; Diaz-Lagares A; Villalba M; Juan O; Crujeiras AB; Calvo A; Sandoval J
Transl Res; 2017 Nov; 189():76-92. PubMed ID: 28644958
[TBL] [Abstract][Full Text] [Related]
16. Implications of intratumour heterogeneity for treatment stratification.
Crockford A; Jamal-Hanjani M; Hicks J; Swanton C
J Pathol; 2014 Jan; 232(2):264-73. PubMed ID: 24115146
[TBL] [Abstract][Full Text] [Related]
17. Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines.
Vural S; Palmisano A; Reinhold WC; Pommier Y; Teicher BA; Krushkal J
Clin Epigenetics; 2021 Mar; 13(1):49. PubMed ID: 33676569
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics and Precision Oncology.
Werner RJ; Kelly AD; Issa JJ
Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.
Moran S; Martinez-Cardús A; Boussios S; Esteller M
Nat Rev Clin Oncol; 2017 Nov; 14(11):682-694. PubMed ID: 28675165
[TBL] [Abstract][Full Text] [Related]
20. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
